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Design and mechanistic insight 
into ultrafast calcium indicators for 
monitoring intracellular calcium 
dynamics
Nordine Helassa1, Borbala Podor2, Alan Fine2 & Katalin Török1
Calmodulin-based genetically encoded fluorescent calcium indicators (GCaMP-s) are powerful tools 
of imaging calcium dynamics from cells to freely moving animals. High affinity indicators with slow 
kinetics however distort the temporal profile of calcium transients. Here we report the development 
of reduced affinity ultrafast variants of GCaMP6s and GCaMP6f. We hypothesized that GCaMP-s have 
a common kinetic mechanism with a rate-limiting process in the interaction of the RS20 peptide 
and calcium-calmodulin. Therefore we targeted specific residues in the binding interface by rational 
design generating improved indicators with GCaMP6fu displaying fluorescence rise and decay times 
(t1/2) of 1 and 3 ms (37 °C) in vitro, 9 and 22-fold faster than GCaMP6f respectively. In HEK293T cells, 
GCaMP6fu revealed a 4-fold faster decay of ATP-evoked intracellular calcium transients than GCaMP6f. 
Stimulation of hippocampal CA1 pyramidal neurons with five action potentials fired at 100 Hz resulted 
in a single dendritic calcium transient with a 2-fold faster rise and 7-fold faster decay time (t1/2 of 40 ms) 
than GCaMP6f, indicating that tracking high frequency action potentials may be limited by calcium 
dynamics. We propose that the design strategy used for generating GCaMP6fu is applicable for the 
acceleration of the response kinetics of GCaMP-type calcium indicators.
Genetically encoded Ca2+ indicators (GECI) facilitated monitoring Ca2+ dynamics in intact and even freely mov-
ing animals. A limiting factor in the application of GECI has been their high Ca2+ affinity and slow response 
kinetics1. In GCaMP-type GECI2–11 Ca2+ binding to calmodulin (CaM) induces the formation of a complex with 
a target peptide which in turn restores the fluorescence of circularly permutated (cp) EGFP12. The Ca2+-induced 
binding of CaM to a target peptide allows the detection of Ca2+ signals also by GCaMP-related G-GECO-s13, 
GEM-GECO-s13 and sub-cellularly targeted CEPIA14 and GCaMPer15. Further broadening of the approaches for 
non-invasive mapping of neuronal circuits is represented by the development of red fluorescent probes for opto-
genetic stimulation and of photoactivatable derivatives13,16–18. The most commonly used target peptide is RS20, 
a smooth muscle myosin light chain kinase-derived peptide and, in the case of RCaMP2, a CaMKKα -derived 
peptide16. GCaMP-s reported to have the greatest brightness and Ca2+ induced fluorescence enhancement to date 
are variants of a GCaMP6 generation termed GCaMP6 slow, GCaMP6 medium and GCaMP6 fast (GCaMP6s, 
GCaMP6m and GCaMP6f)19 as well as GCaMP720 and GCaMP821. Even though indicators such as GCaMP7 
show sufficiently high level of brightness to detect single action potentials (AP-s)22, their slow kinetic properties 
due to the Ca2+ - CaM - RS20 peptide interaction limit achieving temporal fidelity. Typically, Ca2+ - CaM - 
RS20 interactions have a high affinity (half-maximal brightness concentration, Kd values of 100–300 nM) as for 
GCaMP6s and GCaMP6f19. Correspondingly, the Ca2+ dissociation rates and thus the signal decay rates are slow, 
1–5 s−1 at 20 °C, comparable to that of GCaMP310. By rational design, mutations at the Ca2+ - CaM - RS20 binding 
interface have produced GCaMP3- and GCaMP6f-derived probes with improved decay kinetics23,24. The probe 
with the fastest signal rise (t1/2 of 1 ms) and decay (t1/2 of 3 ms) kinetics (37 °C) so far is GCaMP3fast25. The muta-
tion strategy that gave rise to GCaMP3fast can serve as a template for generating fast-response CaM-based GECI.
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Design template for ultrafast GCaMP-s
We developed a strategy to generate fast-response GCaMP-type GECI by introducing specific mutations at the 
Ca2+ - CaM - RS20 peptide interface to weaken their interactions. In CaM, Ca2+ binding sites are disabled by 
asingle-point mutation of the first Asp to Ala in each EF-hand Ca2+ binding loop. The EF-3 mutation denotes a 
mutant with the third Ca2+ site inactivated, EF-4 with the fourth site. A mutation termed RS-1 which substitutes 
the Trp residue in position 43 for Tyr in the RS20 peptide sequence, further weakens the Ca2+- CaM - peptide 
interaction26 (Fig. 1a). Four trends are commonly observed when the mutational strategy is applied to GCaMP3, 
G-GECO and GEM-GECO. First, mutation of EF-1 and/or EF-2 causes loss of fluorescence signal24,25. Second, 
the EF-4 and combined RS-1 EF-4 mutations consistently retain or have increased brightness and dynamic range 
together with faster kinetics than the parent proteins25. Third, GCaMP3, G-GECO and GEM-GECO probes 
with the EF-3:4 double mutation alone or in combination with RS-1 have low affinity (mM Kd) and fast kinet-
ics. Although the lower brightness and dynamic range of the EF-3:4 double mutants requires improvement, 
kinetically they are thus promising for development of extracellular or intra-organelle Ca2+ probes. Finally, the 
combination of mutations EF-3 and RS-1 results in the fastest response kinetics and has given the to-date most 
kinetically improved probe mGCaMP3 RS-1 EF-3 (GCaMP3fast) which has Ca2+ rise and decay times of 1–3 ms25.
Figure 1. Targeted mutagenesis and biophysical characterisation of GCaMP6f and GCaMP6fu. (a) Crystal 
structure of monomeric GCaMP6m in a Ca2+-bound form with cpEGFP (green), Ca2+ ions (yellow), CaM 
(blue) and the RS20 peptide (light brown) (adapted from Ding et al.,27 PDB 3WLD). The positions of the 
mutated amino acid residues in the CaM EF-hand Ca2+-binding sites and in the RS20 peptide are highlighted. 
Equilibrium Ca2+ titrations for GCaMP6f (• ) and GCaMP6fu ( ), (b) at 20 °C (c) at 37 °C. Fluorescence 
changes are normalised to F0 of 0 and Fmax of 1 and fitted to the Hill equation. Fitted curves are represented by 
solid lines overlaying the data points. Ca2+ dissociation kinetics of (d) GCaMP6f and (e) GCaMP6fu at 20 °C 
( ) and 37 °C (—); Experimental data are overlaid by fitted curves using parameters for the kinetic model for 
GCaMPs (Supplementary Table S3). (f) Arrhenius plots of the observed rates for Ca2+ dissociation of GCaMP6f 
(• ) and GCaMP6fu ( ).
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We applied the strategy used to produce GCaMP3fast to the popular bright probes GCaMP6s and GCaMP6f. 
Here we test the hypothesis that the EF-3, EF-4 and RS-1 mutations and their combinations result in signifi-
cantly faster kinetics when applied to CaM-based GECI. We have generated twelve mutant probes, six each for 
GCaMP6s and for GCaMP6f19. Biophysical characterisation revealed that, as predicted, the fastest responding 
probe was given by the RS-1 (W43Y) EF-3 (D395A) mutation combination. mGCaMP6f RS-1 EF-3, termed 
GCaMP6f-ultrafast (GCaMP6fu) has 1 ms rise and 3 ms decay half times in vitro (37 °C). The temperature 
dependence of the fluorescence response kinetics of the probes is analyzed to enable predictions for physiological 
applications and for better understanding of the molecular mechanisms of GCaMP probes. A kinetic model is 
proposed for the processes through which fluorescence develops in CaM-based GCaMP-s. Faster response kinet-
ics by GCaMP6fu compared to GCaMP6f are demonstrated in ATP-stimulated cells and in neurons stimulated by 
high frequency action potentials.
Results
Biophysical properties of GCaMP6fu and selected mGCaMP6s and mGCaMP6f. First the effects 
of the mutations on the fluorescence brightness and dynamic range of the probes were determined. Quantum 
yield (Φ +Ca2+) measurements revealed that the EF-4 and RS-1 EF-4 mutations had little effect on the Φ +Ca2+ 
of GCaMP6s and GCaMP6f. Using the reported value of 0.59 at 20 °C for GCaMP6f19, we obtained a Φ +Ca2+ 
value of 0.58 for GCaMP6s and 0.46 for GCaMP6fu. With measured molar extinction coefficients εo(497 nm) of 
50294 ± 259 M−1cm−1 for Ca2+-saturated GCaMP6f and 1564 ± 1140 M−1cm−1 for Ca2+-saturated GCaMP6fu, 
brightness values of 29673 and 7197 M−1cm−1 were obtained for GCaMP6f and GCaMP6fu, respectively. 
Similarly, Ca2+-induced fluorescence increases (Fr(+Ca2+)), expressed relative to apo-GCaMP6s (Fr(−Ca2+) 
of 1)) of 27 for GCaMP6s and 15 for GCaMP6f19, were little affected by the EF-4 and RS-1 EF-4 mutations. 
Fr(+Ca2+)/Fr(−Ca2+) of GCaMP6s RS-1 EF-3 and GCaMP6fu were reduced to 18 and 5, respectively (Table 1 and 
Supplementary Table S1). Even though the brightness for GCaMP6fu is 4-fold reduced compared to GCaMP6f, 
the value remains comparable to GCaMP3 probe which has been widely used for in vivo experiments includ-
ing calcium measurements in free-moving animals (Fmax/Fmin for GCaMP6f = 14.6, GCaMP6fu = 5.1 and 
GCaMP3 = 6.3)25. pKa values of ~7 were measured for GCaMP6s and GCaMP6f together with their mutants at 
20 °C in agreement with previously reported values (Supplementary Fig. S1)19.
Equilibrium Ca2+ binding. The mutations were expected and found to increase the equilibrium half-maximal 
brightness concentration (Kd) values of the probes. Cooperativity for Ca2+ remained high, characterised by Hill 
coefficient (n) values of ~2–3. Comparison of affinities at 20 °C and 37 °C revealed that Kd-s decreased with 
increasing temperature: for GCaMP6f, from 220 nM to 88 nM, respectively (Fig. 1b), for GCaMP6fu from 890 nM 
to 340 nM (Fig. 1c, Table 1) and for the lower affinity mGCaMP6f EF-4, from 1.6 μ M to 840 nM (Supplementary 
Fig. S2,S3, Supplementary Table S1).
mGCaMP6f RS-1 EF-4 and the EF-3:4 double mutants of both GCaMP6s and GCaMP6f revealed two inde-
pendent sets of Ca2+ binding sites: high affinity (1–6 μ M Kd) with n of 2 and low affinity (0.2–6 mM Kd) with n of 
1. The high affinity Kd decreased with temperature while the low affinity Kd increased. Moreover, while 80% of the 
total fluorescence enhancement of mGCaMP6f RS-1 EF-4 occurred with high affinity at 20 °C, at 37 °C, a temper-
ature closer to those in physiological applications, the lower affinity component dominated representing 70% of 
the signal (Supplementary Fig. S3 and Supplementary Table S1, S2). The apparent binding to three sites shown by 
the EF-3:4 double mutants may be explained by residual Ca2+ binding to a mutated C-lobe site.
Ca2+ decay kinetics. Typically, faster fluorescence decay rates were expected for the EF-3, EF-4 and RS-1 mutants 
of GCaMP6s and GCaMP6f compared to their parent proteins at all temperatures (Supplementary Fig. S4, S5). 
t1/2 at 20 °C of 769 ms for GCaMP6s was reduced to 216 ms by the RS-1 EF-3 mutation. The same mutation 
in GCaMP6f, giving GCaMP6fu brought down the decay t1/2 from 288 ms to 7.8 ms (Fig. 1e, Table 1 and 
Supplementary Table S1).
In spite of decreasing Kd values by increased temperatures, the fluorescence decay rates were 2–5-fold 
increased at 37 °C compared to 20 °C (Supplementary Fig. S4,S5 and Supplementary Tables S1,S2). At 37 °C, 
the fastest mGCaMP6s probe, mGCaMP6s RS-1 EF-3, had a 6.5-fold increased Ca2+ decay rate compared to 
GCaMP6s with the t1/2 of 346 ms reduced to 53 ms. t1/2 at 20 °C of 288 ms of GCaMP6f was reduced to 63 ms at 
37 °C (Fig. 1d). The most significant improvements in the Ca2+ dissociation kinetics were however achieved by 
Fr
Fr(+Ca2+)/Fr(−Ca2+) Kd (μM) n kon (s−1) t1/2(on) (ms) koff (s−1) t1/2(off) (ms)−Ca2+ +Ca2+
GCaMP6f
20 °C 0.9 ± 0.1 14.4 ± 3.4 14.6 ± 2.4 0.22 ± 0.01 2.8 ± 0.1
315 ± 9 (0.3)a 2.2 ± 0.1 (0.3)a
2.4 ± 0.1 288 ± 12
38 ± 1 (0.7)a 18 ± 0.5 (0.7)a
37 °C 1.0 ± 0.1 13.8 ± 0.1 13.2 ± 0.1 0.09 ± 0.01 3.4 ± 0.1 66 ± 1 10 ± 0.2 11 ± 1 63 ± 6
GCaMP6fu 
(mGCaMP6f RS-1 EF-3)
20 °C 1.0 ± 0.1 5.1 ± 0.4 5.1 ± 0.1 0.89 ± 0.01 3.0 ± 0.1 142 ± 4 4.9 ± 0.1 89 ± 1 7.8 ± 0.1
37 °C 0.9 ± 0.1 3.8 ± 0.2 4.1 ± 0.2 0.34 ± 0.01 3.0 ± 0.3 546 ± 44b 1.3 ± 0.02b 245 ± 10 2.8 ± 0.1
Table 1. Comparison of the biophysical characteristics of GCaMP6f and GCaMP6fu. aBiphasic association 
kinetic records were fitted with two exponentials. The rise t1/2 of each phase is given with the relative amplitudes 
in parentheses. bMeasurements were made in the range of 15 to 30 °C. The rate was too fast to measure at 37 °C 
and was extrapolated from the Arrhenius plot assuming the gradient remaining unchanged (Fig. 2e).
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the RS-1 EF-3 mutations of GCaMP6f yielding the probe GCaMP6fu with a 23-fold faster fluorescence decay t1/2 
of 3 ms at 37 °C (Fig. 1f and Supplementary Fig. S6).
Ca2+ rise kinetics. Stopped-flow fluorimetry revealed biphasic Ca2+ association kinetics for both GCaMP6s and 
GCaMP6f and for most of their mutants at 20 °C. The exceptions were mGCaMP6s RS-1 EF-4, GCaMP6fu and 
mGCaMP6f EF-3:4 which had a monophasic fluorescence rise (Fig. 2 and Supplementary Fig. S7, S8). [Ca2+] 
dependency of the rise rates revealed a switch-like response with limiting rates for each phase (kon(lim)). The fastest 
rate was measured for GCaMP6fu which, responding in an all-or-none manner to [Ca2+] rise, had a single rise t1/2 
of 5 ms at 20 °C (Fig. 2c).
Examination of the temperature dependence of the Ca2+ rise kinetics reveals the kinetic advantage of 
GCaMP6fu over GCaMP6f at 37 °C (Fig. 2 and Supplementary Fig. S9). The fast phase of Ca2+ induced fluores-
cence enhancement of GCaMP6f has a limiting rate of 315 s−1 (rise t1/2 2 ms) and at 20 °C represents 30% of the 
fluorescence enhancement. The rate of the fast phase is essentially independent of temperature in the range of 
20 °C to 30 °C, however with a diminishing amplitude of only 10% at 30 °C and no longer measurable at 37 °C. 
The rate of the slow phase is ~2-fold increased from 38 s−1 to 66 s−1 over the temperature range of 20 °C to 37 °C, 
representing the only measurable rate for GCaMP6f at 37 °C. The apparent Ca2+ response of GCaMP6f is thus 
slower at 37 °C than 20 °C. In contrast, the single observed limiting rate for mGCaMP6f RS-1 EF-3 (GCaMP6fu) is 
~4-fold increased, to an extrapolated 546 s−1 at 37 °C, from 142 s−1 at 20 °C giving a fluorescence rise time of 1 ms.
Complexities are revealed in the temperature dependencies of the Ca2+ rise kinetics of GCaMP6s and 
mGCaMP-s as well (Fig. 2, Supplementary Fig. S10). In the case of GCaMP6s, the relative amplitudes of 
the fast and slow phases change with temperature such that at physiological ionic strength and 20 °C the 
amplitudes are about even, however at 37 °C the slow phase (rise t1/2 12 ms) represents 90% of the signal 
(Supplementary Table S1). Arrhenius plots for mGCaMP6f RS-1 EF-4 reveal opposite temperature dependencies 
for the rate of the fast and slow phases of its biphasic Ca2+ association kinetics: while the rate of the fast phase is 
2-fold increased, the rate of the slow decay component is 2.5-fold lowered when the temperature increases from 
20 °C to 37 °C (Supplementary Fig. S11d and Supplementary Table S1).
Kinetic mechanism of GCaMP-type GECI. As the fluorescence increase evoked by Ca2+ is based on the effect of 
the Ca2+ - CaM - RS20 peptide interaction on the structure of the cpEGFP domain, a common reaction mech-
anism previously described for GCaMP3 and its fast variants is expected to operate for GCaMP-s in general25. 
In essence, partially and fully Ca2+- and peptide-bound intermediates create two main fluorescent states in 
the rise phase of Ca2+-induced fluorescence. In the decay phase evoked by Ca2+ sequestration, Ca2+ leaving 
initiates dissociation of the complex and the return to the resting low-fluorescence state (Fig. 3). Fitted curves 
to the stopped-flow kinetic Ca2+ association and dissociation records obtained at 20 °C, 30 °C and 37 °C for 
GCaMP6f and GCaMP6fu were generated using a set of fitted parameters consistent with the data (Fig. 2 and 
Supplementary Table S3).
Fluorescence dynamic range measurements of GCaMP6f and GCaMP6s variants in HEK293T cells. 
Fluorescence dynamic range values for mGCaMP6s and mGCaMP6f probes were measured in ionomycin stim-
ulated HEK293T cells. GCaMP6s continued to have the greatest fluorescence enhancement with Δ F/F0 of 18. In 
contrast to Δ F/F0 for GCaMP6f of 11, GCaMP6fu had Δ F/F0 of ~ 7. Fluorescence dynamic range values obtained 
in cellular environment were generally reduced compared to those in solution, except for GCaMP6fu, and for 
mGCaMP6s EF-3:4 (Supplementary Fig. S12).
Imaging intracellular Ca2+ release dynamics in ATP-stimulated HEK293T cells by GCaMP6f, 
GCaMP6fu and mGCaMP6f RS-1 EF-4. Intracellular Ca2+ dynamics were monitored in ATP-stimulated 
HEK293T cells and the time courses of the Ca2+ transient evoked by GCaMP6f, GCaMP6fu and mGCaMP6f RS-1 
EF-4 were compared. GCaMP6f fluorescence increased (Δ F/F0 of 3.1 ± 0.35) with a decay time t1/2 of 9.4 ± 0.2 s. 
In comparison, GCaMP6fu and mGCaMP6f RS-1 EF-4 both showed lower dynamic ranges (Δ F/F0 of 0.2 ± 0.02) 
and significantly reduced, 2.3 ± 0.04 s decay time. Faster probes GCaMP6fu and mGCaMP6f RS-1 EF-4 thus 
revealed that ATP-induced intracellular Ca2+ release dynamics were more rapid than reported by GCaMP6f 
(Fig. 4a).
Response of GCaMP6f, GCaMP6fu and mGCaMP6f RS-1 EF-4 to high frequency stimulation in 
neurons. GCaMP6f, GCaMP6fu and mGCaMP6f RS-1 EF-4 expressed in hippocampal CA1 pyramidal neu-
rons in organotypic hippocampal slices were distributed homogenously. Baseline fluorescence of all three indica-
tors was bright enough to readily identify expressing cells. Fluorescence dynamic ranges (Δ F/F0) were 5.9 ± 0.3, 
0.8 ± 0.05 and 0.5 ± 0.04 for GCaMP6f, GCaMP6fu and mGCaMP6f RS-1 EF-4, respectively, consistent with small 
[Ca2+] changes. Notably, GCaMP6f achieved a significantly higher Δ F/F0 value throughout the 10–100 Hz range 
tested compared to GCaMP6fu and mGCaMP6f RS-1 EF-4. Due to its low Kd for Ca2+, only GCaMP6f was able to 
detect the low post-synaptic [Ca2+] elevation evoked by 5 AP-s fired at 10 Hz. For the same reason, however, the 
kinetics of GCaMP6f response were the most prolonged. With their higher Kd values GCaMP6fu and mGCaMP6f 
RS-1 EF-4 did not show a response to stimulation up to 20–40 Hz frequency and the dynamic range remained low. 
The kinetic advantage of GCaMP6fu and mGCaMP6f RS-1 EF-4 became evident at stimulation at 40 Hz or greater 
(Fig. 4b,c and Supplementary Fig. S13) and was particularly clear at 100 Hz: compared to GCaMP6f, GCaMP6fu 
and mGCaMP6f RS-1 EF-4 responded with much faster rise and decay kinetics to the [Ca2+] elevation evoked by 
trains of 5 AP-s. For GCaMP6f, following 50 ms stimulation at 100 Hz, the Ca2+ signal is still rising for another 
~ 75 ms and then decays over ~ 400 ms19 (Fig. 4b). mGCaMP6f RS-1 EF-4 has improved kinetics with the signal 
decaying only~20 ms after stimulation, with a t1/2 of 91 ± 17 ms (Supplementary Fig. S13). The fastest response 
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is achieved by GCaMP6fu: the Ca2+ signal decay commences as soon as the stimulation is finished, and returns 
to baseline with a t1/2 of 40 ± 2 ms, thus reducing the refractory period of detection following a stimulation event 
from hundreds to tens of milliseconds (Fig. 4c).
Figure 2. Ca2+ association kinetics of GCaMP6f at (a) 20 °C and (b) 37 °C; (c) GCaMP6fu at 20 °C. Left hand 
panels show stopped-flow records at the specified final [Ca2+] values. Fluorescence changes are normalised to F0 
of 0 and maximum of 1. Experimental data (dotted lines) are overlayed with fitted curves (solid lines) generated 
using the parameters shown in Supplementary Table S3 fitted to the kinetic model for GCaMP-s. Right hand 
panels show plots of the [Ca2+] dependence of the observed rate(s) (kobs). GCaMP6f has biphasic association 
kinetics at 20 °C; the fast phase ( ) corresponds to 30% and the slow phase (• ) to 70% of the fluorescence 
amplitude. At 37 °C, GCaMP6f Ca2+ association kinetics are monophasic with the fluorescence response shown 
only by the slow phase. (d) Stopped-flow record of GCaMP6fu Ca2+ association at 10 μ M final [Ca2+] measured 
at 30 °C, fitted to the model. (e) Arrhenius plots of the observed rates for Ca2+ association of GCaMP6f fast 
phase ( ), slow phase (• ), GCaMP6fu ( ). For GCaMP6f the amplitude of the fast phase diminishes with 
increasing temperature: relative amplitudes are at 20 °C, fast (0.3) slow (0.7); at 25 °C, fast (0.2) slow (0.8); at 
30 °C, fast (0.1) slow (0.9) and at 37 °C, fast (0) slow (1.0).
www.nature.com/scientificreports/
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Discussion
The aim of this work was to reveal generally applicable modifications for the generation of fast-response 
GCaMP-like GECI for more accurate time resolution of Ca2+ signalling events. The combination of RS-1 and 
EF-3 mutations gave mGCaMP3 RS-1 EF-3 (GCaMP3fast) which has a 1 ms rise and 3 ms decay t1/2 at 37 °C25. The 
application of GCaMP3fast in cardiac myocytes revealed faster Ca2+ transients then previously indicated by slow 
indicators25. Here we report that the same design template when used on GCaMP6f results in similarly fast on 
and off response kinetics and propose that the RS-1 EF-3 mutation combination is applicable for the generation 
of ultrafast GCaMP-s.
While the RS-1 (W43Y) EF-3 (D395A) mutation pair has equal effects on the kinetics of GCaMP3 and 
GCaMP6f, they differently affect the brightness and dynamic range of their parent variants: GCaMP3fast retains 
the brightness of GCaMP3, whereas GCaMP6fu is 4-fold decreased compared to GCaMP6f. Even though 
GCaMP6m is significantly brighter than GCaMP3, the alignment of their crystal structures (PDB codes 3SG3 
and 3WLD) reveals only subtle differences in the position of helix I and the linker region to cpEGFP3,27. The 
brightness and fluorescence dynamic range of GCaMP6f are higher than of GCaMP3 because of the introduction 
of the ‘stabilising’ mutations in the linker region connecting the CaM N-terminus to cpEGFP (T302L, R303P) 
and in helices I, IV and V of CaM (A317E, D380Y/T381R/S383T, R392G, respectively) (Fig. 5a,b). In particular, 
the T302L, R303P, D380Y hydrophobic mutations at the interface between CaM and cpEGFP result in similarly 
Figure 3. Schematic model of the kinetic mechanism of GCaMPs. General model for the mechanism of 
Ca2+-induced fluorescence of GCaMP-type probes depicting Ca2+ binding to the CaM N- and C-lobe followed 
by peptide binding and isomerisation leading to fluorescent states. Fluorescence is proposed to derive from the 
equilibrium of two states: in the first, Ca2+-bound CaM N-lobe is with the P1 CaM binding site of RS20; in the 
second, both the N- and C-lobes of CaM are Ca2+-bound binding to both the P1 and P2 sites of the peptide. 
Formation of the fluorescent complexes involves essentially irreversible processes. Peptide release is triggered 
by Ca2+ sequestration returning the complex to the apo-state. This general model for GCaMPs is applicable to 
EF-hand mutants by omitting the appropriate Ca2+ binding steps e.g. eq. 1 for the EF-1 mutant, eq. 2 for EF-2 
and so on25.
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Figure 4. Ca2+ response of GCaMP6f and GCaMP6fu in ATP-stimulated HEK293T cells and post-synaptic 
CA1 neurons in hippocampal slices. (a) Ca2+ transients were triggered by exposure of HEK293T cells to 
100 μ M ATP. Time courses of response of GCaMP6f and GCaMP6fu are shown. t1/2 for GCaMP6fu 2.3 ± 0.04 s 
was significantly different from that for GCaMP6f (9.4 ± 0.2 s). (b) Ca2+ response kinetics in post-synaptic 
CA1 neurons in hippocampal slices of GCaMP6f (28 °C) to stimulation by 5 action potentials (AP-s). Grey 
shaded areas indicate the duration of stimulation. GCaMP6f stimulated at (3 cells, n number of recordings in 
brackets) 10 Hz (n = 28), 20 Hz (n = 28), 40 Hz (n = 29), 50 Hz (n = 27), 75 Hz (n = 30) and 100 Hz (n = 19); 
(c) GCaMP6fu stimulated (4 cells, n number of recordings in brackets) at 10 Hz (n = 29), 20 Hz (n = 30), 40 Hz 
(n = 29), 50 Hz (n = 29), 75 Hz (n = 30) and 100 Hz (n = 26). The achieved maximum Δ F/F0 values are plotted 
against time. Inset images: representative images baseline expression of GCaMP6f and GCaMP6fu in CA1 
pyramidal neurons with white line in the position of the line scan.
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increased brightness and dynamic range in GCaMP5G and GCaMP6f3,19. The gain of brightness is likely due to 
a structural rearrangement involving these crucial hydrophobic residues not present in GCaMP3 as described 
below. These mutations decrease the flexibility of the cpEGFP - CaM helix I linker, through interaction between 
helix IV-V and cpEGFP - CaM helix I linkers. Specifically, the T302L, R303P, D380Y mutations play the most sig-
nificant roles in ordering/positioning cpEGFP - CaM helix I linker, as GCaMP5G is almost as bright as GCaMP6f. 
The R303P mutation decreases flexibility and increases order in the cpEGFP - CaM helix I linker, thus positioning 
the mutated L302 and Y380 hydrophobic sidechains in proximity allowing them to form tertiary interactions. 
Figure 5. Comparison of fast GCaMP probes (GCaMP3fast and GCaMP6fu) and their parent variants 
(GCaMP3 and GCaMP6f). (a) Position of the mutations that gave rise to GCaMP3fast and GCaMP6fu variants, 
relative to GCaMP3. (b) Crystal structure of monomeric GCaMP6m in a Ca2+-bound form with cpEGFP 
(green), Ca2+ ions (yellow), CaM (blue) and the RS20 peptide (light brown) (adapted from Ding et al.,27 PDB 
3WLD). The amino acid residues highlighted in red are those that generated GCaMP6fu relative to GCaMP3. 
Schematic representation of (c) Ca2+-bound GCaMP3/GCaMP6f showing “open” conformation of EF-hand 
3 (helices V and VI); (d) Ca2+-bound GCaMP3fast/GCaMP6fu showing “closed” conformation of disabled EF-
hand 3 (helices V and VI).
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In GCaMP6f, the cpEGFP - CaM helix I and helix IV-V linkers interact and stabilise one another. Thus the 
three mutations position the cpEGFP - CaM helix I linker with respect to RS-20 peptide - cpEGFP linker sta-
bilising cpEGFP folding. In contrast, the T302, R303 and D380 residues, originally present in GCaMP3, allow 
the cpEGFP - CaM helix I linker to be more dynamic, thus increasing entropic penalty for cpEGFP folding in 
GCaMP3 with respect to GCaMP6f. In GCaMP3, the cpEGFP - CaM helix I linker and helix IV-V linkers are 
dynamic, reducing the stability of folded cpEGFP, explaining/causing its reduced brightness, which is the measure 
of the fraction of folded cpEGFP. The D395A mutation, introduced in GCaMP3fast and GCaMP6fu, prevents Ca2+ 
binding to the EF-3 site (flanked by helices V and VI), which thus, rather than being in an “open” conformation 
as in Ca2+-bound GCaMP-s (Fig. 5c), is expected to remain in “closed” conformation (Fig. 5d). Thus, the cpEGFP 
- CaM helix I linker is imperfectly poised with respect to RS-20 peptide - cpEGFP linker, cpEGFP folding is 
thus destabilised and the brightness is reduced in GCaMP3fast and GCaMP6fu. In GCaMP3, the CaM EF-hand 
3 adopts “open” conformation, but the cpEGFP - CaM helix I linker remains dynamic, hence cpEGFP folding 
is still destabilised explaining its similar brightness to GCaMP3fast and GCaMP6fu. Closing the CaM EF-hand 3 
conformation by the W43Y/D395A mutation thus has the equivalent effect on cpEGFP folding as destabilising 
the cpEGFP - CaM helix I linker.
We observed that GCaMP-type GECI have a limiting response rate that is independent of [Ca2+]25. Moreover, 
the Ca2+ rise kinetics of GCaMP6s and GCaMP6f revealed complex biphasic processes: although at 20 °C 
GCaMP6s and GCaMP6f have 20 ms and 2 ms response times, the amplitude of their fast phase diminishes with 
increasing temperature, thus presenting as slow indicators, at 37 °C. In contrast, GCaMP3fast and GCaMP6fu 
have greatly improved fluorescence rise time of 1 ms t1/2 at 37 °C. By targeting the CaM - RS20 peptide interface, 
GCaMP3 RS09 and GCaMP6f RS09 had improved decay t1/2-s of 25 and 20 ms (37 °C)23,24, compared to decay 
t1/2-s of GCaMP3 with 147 ms and GCaMP6f with 71 ms. However GCaMP3fast25 and GCaMP6fu have the fastest 
decay with a t1/2 of 3 ms, at 37 °C.
The fluorescence response kinetics of GCaMP-s have been modelled from the stopped-flow data. Previously a 
model has been put forward in which the Ca2+ response rate depends on the Ca2+ step: a small Ca2+ step results in 
slow binding to the C-lobe followed by fast binding to the low affinity the N-lobe; in contrast, a large step in Ca2+ 
evokes fast Ca2+ response via N-lobe binding and in this mode C-lobe binding is not required for the fluorescent 
state24. Our modeling studies reveal a different mechanism: first, that although N-lobe Ca2+ binding is necessary 
for Ca2+-induced fluorescence enhancement, it is not sufficient for the fluorescence response which also requires 
C-lobe Ca2+-binding; second, the limiting rate of the probes is determined by the Ca2+ association kinetics of 
the C-terminal CaM lobe in conjunction with the re-equilibration of the two postulated fluorescent states. Ca2+ 
binding is of lower affinity to the CaM N-lobe than to the C-lobe, however, in the presence of a target peptide 
the Ca2+ affinity of the N-lobe may be similar or higher than that of the C-lobe28. The Ca2+ binding kinetics of 
CaM-peptide complexes have not been determined, thus the rate constants for CaM were used29. Ca2+ dissoci-
ation from CaM and its peptide complexes is commonly thought to occur in pairs of Ca2+. Whether a single or 
double exponential process is observed for the fluorescence decay depends on the rates by which the putative 
two- and four-Ca2+ saturated states convert into each other and decay26.
Temperature dependencies of the Ca2+ rise kinetics suggest complex underlying activation thermodynam-
ics. Positive, neutral and negative temperature-induced rate changes all occur, indicating that the EF-hand 
and peptide mutations have sensitively affected the balance of entropy and enthalpy gains. Favourable dehy-
dration of hydrophobic surfaces results in entropy-driven activation and a positive temperature coefficient30. 
The lack of temperature dependence of the rates, e.g. GCaMP6f fast on-rate, is consistent with the limiting fast 
rate being Ca2+ binding, a diffusion limited process. Negative temperature coefficients observed for EF-3 and 
EF-3:4 mutants likely stem from less hydrophobic interaction and hence less positive entropy and more negative 
enthalpy change deriving from CaM C-lobe interaction with peptide in the absence of EF-3 or EF-4 Ca2+ binding 
and weakened binding of peptide due to W to Y substitution. Reduced brightness appears to be a trade-off for fast 
kinetics, presenting an opportunity for future improvements. While the EF-3 Ca2+ binding site is responsible for 
brightness, the EF-4 site is the guardian of cooperativity of the C-terminal CaM lobe for Ca2+ when binding the 
RS20 target peptide.
A commonly observed property of cpEGFP- and CaM-peptide interaction-based GECI is high cooper-
ativity for Ca2+, often showing an all-or-none response to Ca2+ elevation as revealed by stopped-flow kinetic 
experiments on GCaMP3fast25 and GCaMP6fu. Fast all-or-none response to small changes in [Ca2+] would make 
GCaMP-type probes well suited for spike detection, however the current fast variants have insufficient brightness. 
RCaMP2 and some mGCaMP3, mG-GECO and mGEM-GECO have slower kinetics and reduced cooperativity 
for Ca2+ with Hill coefficients of 1–1.7 16,25, possibly by a combination of negatively and positively cooperative 
molecular responses, making them potentially useful for quantifying [Ca2+] changes in cells.
While the EF-3 single mutation raises the Kd to low μ M, the EF-4 single and the EF-3:4 double mutations 
break up the affinity into two components, one with a Kd of low μ M and one in the mM range with most of the 
fluorescence enhancement occurring in mM Ca2+. In the kinetic modeling only high affinity sites with μ M Kd 
are considered. As there are only two Ca2+ binding sites in the EF-3:4 mutants, the low, mM affinity Ca2+ binding 
is likely attributable to the mutated EF-hand 3 (necessary for high brightness and dynamic range) which in the 
presence of the RS20 target peptide may acquire such affinity for Ca2+. EF-3:4 double EF-hand mutant probes 
with mM Kd-s may be for suitable for intra-organelle and extracellular applications, after further improvements to 
their brightness and dynamic range. mGCaMP6s EF-3:4 is the most promising low affinity probe with a 500 μ M 
Kd and a 19-fold Ca2+-induced fluorescence enhancement (20 °C), comparing favourably with CEPIA14.
The success of monitoring intracellular Ca2+ dynamics requires that the detection range of the probe is 
appropriate for the size and time course of the [Ca2+] transient. In the conditions of ionomycin stimulation, 
the expected peak [Ca2+] was 0.4 to 0.8 μ M31. GCaMP6s with Kd of 110 nM, 5–10-fold lower than the peak of 
the [Ca2+] transient, was thus expected to be mostly saturated and thus signal such a transient with close to its 
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maximum dynamic range. However, at resting [Ca2+] of ~ 50–80 nM, there is already considerable Ca2+ binding 
to such a probe. As a result of the two parameters the measured Δ F/F0 of 18 for GCaMP6s in ionomycin stimu-
lated HEK293T cells is a reasonable value.
Regarding the kinetics of Ca2+ indicators, it is evident that low Kd probes with slow response report slower 
intracellular Ca2+ dynamics than higher Kd probes with fast responses. GCaMP6fu and mGCaMP6f RS-1 EF-4 
both showed 4-fold faster Ca2+ decay in response to ATP stimulation than GCaMP6f. By its two-fold faster 
response rate, in cardiac myocytes, GCaMP3fast revealed removal of Ca2+ and return to resting intracellular levels 
between each beat, a phenomenon not clearly resolved by GCaMP6f25.
It transpires that the brightness and dynamic range of GCaMP6fu are not sufficient for the detection of the 
post-synaptic dendritic [Ca2+] elevation evoked by a single AP. Although the kinetic properties of GCaMP6fu 
would allow the separation of individual AP-s even at 100 Hz, the actual Ca2+ transient reveals an integrated 
Ca2+ response, raising the possibility that the Ca2+ dynamics associated with AP firing limit the use of Ca2+ as an 
indicator of neuronal activity.
Although unable to detect single AP-s, GCaMP6fu with its fast rise and decay kinetics may still be useful for 
the detection of repeated AP-s with between-train intervals of tens rather than hundreds of milliseconds. The 
Ca2+ induced fluorescence rise times of GCaMP3 RS09 and GCaMP6f RS09 remained slow in physiological 
experiments23,24. In contrast, the Ca2+ rise rates following a train of 5 AP-s in organotypic hippocampal slices 
reported by the GCaMP6fu and mGCaMP6f RS-1 EF-4 probes were markedly faster than GCaMP6f. When com-
paring the novel variant GCaMP6fu to GCaMP3fast25, though they show similar kinetic properties, GCaMP6fu 
which has a 3-fold lower Kd (0.89 μ M) compared to GCaMP3fast (2.8 μ M) is more sensitive to small Ca2+ con-
centration changes and hence more suitable for Ca2+ imaging in neurons. Improved brightness and fluorescence 
dynamic range would help make GCaMP6fu with its ultrafast kinetics a useful physiological tool.
Materials and Methods
Materials. GCaMP6s and GCaMP6f plasmids were a gift from Douglas Kim (Addgene plasmid #40753 and 
#40755, respectively)19. pET41a and pEGFP-N1 vectors were obtained from Novagen and Clontech, respectively. 
XL10-Gold and BL21 (DE3) Gold cells were purchased from Invitrogen. Restriction enzymes were obtained from 
New England Biolabs and T4 DNA ligase from Fermentas.
Generation of improved GCaMP6 probes. The strategy previously developed and described for 
the improvement of GCaMP3 probes was followed to design, generate and purify mutants of GCaMP6s and 
GCaMP6f probes19. For protein expression, GCaMP6s and GCaMP6f were subcloned from pGP-CMV back-
bone into pET41a bacterial expression vector. Mutant GECI were generated by site-directed mutagenesis of CaM 
EF-hands and RS20 peptide as previously described25. GCaMP6s and GCaMP6f and their mutants were overex-
pressed as GST-fusion proteins overnight at 20 °C in the presence of 0.5 mM IPTG in E. Coli BL21(DE3) Gold 
cells. Cells were lysed by sonication and clarified lysates were purified by a single-step GST-chromatography 
(GSTrap, ÄKTA Purifier, GE Healthcare) in 50 mM Na+-HEPES pH 7.5, 200 mM NaCl and 10 mM glutathione, 
at 4 °C. Purity of the eluted fractions was determined by SDS-PAGE (6.4%–20% acrylamide/bisacrylamide gra-
dient). Protein concentrations were measured spectroscopically at 280 nm by a Nanodrop 1000 spectrophotom-
eter (Thermo Scientific) using an εo value of 76585 M−1cm−1 calculated from the amino acid composition for 
GCaMP6s, GCaMP6f and their EF-hand mutants and εo of 70710 M−1cm−1 for the RS-1 mutants32.
Quantum yield determination. Protein concentrations were adjusted such that the absorbance at the 
excitation wavelength (490 nm) was between 0.001 and 0.1. A series of dilutions was prepared in a buffered solu-
tion (50 mM HEPES-K+ pH 7.5, 100 mM KCl, 2 mM MgCl2 with either 5 mM EGTA or 1 mM CaCl2) and the 
fluorescence spectra were recorded on a Fluorolog3 spectrofluorimeter (Horiba Scientific) at 20 °C. The quantum 
yield measured for GCaMP6f in Ca2+-saturated buffer was used as a reference (Φ = 0.59)19. Data were plotted as 
integrated fluorescence intensity as a function of absorbance and fitted by linear regression. The gradient of the 
plots for the reference GCaMP6f and the protein to be measured are termed SGCaMP6f and Sprotein, respectively. 
Quantum yields were obtained using the following equation: Φ protein = Φ GCaMP6f × (Sprotein/SGCaMP6s).
pH sensitivity of GCaMP6s and GCaMP6f-derived proteins. To determine the apparent pKa for 
each protein in the presence and absence of Ca2+, a series of buffers with 0.5 pH unit intervals were prepared. 
Depending on their respective pH buffering range, appropriate buffer was used for the measurements (MES for 
pH 6–6.5, HEPES for pH 7–8, TRIS for pH 8.5–9 and CAPS for pH 10). The pH titrations were performed by 
recording fluorescence spectra of 1 μ M protein in Ca2+-free (50 mM buffer, 100 mM KCl, 2 mM MgCl2, 2 mM 
BAPTA) or Ca2+-saturated (50 mM buffer, 100 mM KCl, 2 mM MgCl2,1 mM CaCl2) conditions (Fluorolog3, 
Horiba). BAPTA was chosen over EGTA as Ca2+ chelator because of its stable affinity for Ca2+ over the pH 
range33. All titrations were performed in triplicates and expressed as normalised mean ± s.e.m.
Determination of free Ca2+ concentrations ([Ca2+]). [Ca2+] were calculated using the Ca/Mg/ATP/EGTA 
Calculator v1 constants from Schoenmakers’ Chelator program for experiments at 20 °C and 37 °C34.
Equilibrium Ca2+ binding. Ca2+ affinity assays of GECI and mGECI were performed by continuous titration 
using an automated syringe pump (ALADDIN 1000, WPI) at 20 oC or 37 °C. GECI proteins at 50–100 nM con-
centration (50 mM K+-HEPES pH 7.5, 100 mM KCl, 2 mM MgCl2 and 5 mM EGTA) were titrated with 325 mM 
CaCl2 at a 10 μ L/min flow rate in a stirred 3 mL cuvette. Fluorescence was measured at 492 nm excitation and 
515 nm emission wavelengths on a Fluorolog3 spectrofluorimeter (Horiba Scientific). Fluorescence records were 
corrected for dilution and photobleaching. Data were normalised and expressed as bound fraction. Half-maximal 
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brightness concentration (Kd) and cooperativity for Ca2+ (n) were obtained by fitting the data to the Hill equation 
using GraphPad Prism 6 software. All titrations were performed at least in triplicates and expressed as mean ±  s.e.m.
Stopped-flow fluorimetry. Ca2+ association and dissociation kinetic experiments of GCaMP6s and 
GCaMP6f proteins were carried out on a Hi-Tech Scientific SF-61DX2 stopped-flow system at temperatures 
ranging from 15 °C to 37 °C. Fluorescence excitation was set to 492 nm and fluorescence emission was collected 
using a 530 nm cut-off filter. Experiments were performed at least in triplicates and three sets of data were aver-
aged for analysis. Data were fitted to either a single or a double exponential to obtain the rise or decay rates using 
KinetAssyst software.
Association kinetics. The solution containing 1 μ M protein in 50 mM K+-HEPES pH 7.5, 100 mM KCl, 2 mM 
MgCl2 and 10 mM EGTA was rapidly mixed (1:1) with 50 mM K+-HEPES pH 7.5, 100 mM KCl, 2 mM MgCl2 
and 10 mM EGTA containing increasing [Ca2+] concentrations (concentrations in the mixing chamber). For the 
determination of temperature dependence of Ca2+ association rates, protein samples at 1 μ M concentration were 
mixed as above with saturating Ca2+ (7.5–20 μ M final [Ca2+] in the mixing chamber).
Dissociation kinetics. The solution containing 1 μ M protein in 50 mM K+-HEPES, 100 mM KCl, 2 mM MgCl2, 
pH 7.5 with saturating Ca2+ (0.5 mM) was rapidly mixed (1:1) with 50 mM K+-HEPES, 100 mM KCl, 2 mM 
MgCl2, 10 mM EGTA pH 7.5 (concentrations in the mixing chamber).
Cloning of mGECI into a mammalian expression vector. For expression in eukaryotic cells, 
the GCaMP6s and GCaMP6f mutant DNAs were subcloned from pET41a into pEGFP-N1 vectors by 
restriction-ligation using BglII and NotI restriction enzymes and T4 DNA ligase following manufacturer’s pro-
tocol. During this process, the egfp initially present in the pEGFP-N1 vector was replaced by the gcamp6 genes 
(without the GST tag).
Imaging of GCaMP6f variants in HEK293T cells. Cells were cultured in DMEM containing 10% fetal 
bovine serum and 1% penicillin/streptomycin at 37 °C and 5% CO2.
Ionomycin stimulation. Transfection of cells was carried out on 10 mm diameter coverslips with 0.6 μ g 
DNA and 2.5 μ L Lipofectamine 2000 in 100 μ L OptiMem® for 1 h at 37 °C. Cells were imaged 16–24 h 
post-transfection in 10 mM HEPES pH 7.5, 145 mM NaCl, 2.5 mM KCl, 1 mM MgCl2, 10 mM glucose and 2 mM 
CaCl2. For determination of the fluorescence dynamic range, cells were imaged before and after stimulation 
by 10 μ M ionomycin at 20 °C. Imaging was performed with a Leica SP1 confocal microscope using a HCX 
ApoL 40 × 0.8 NA water immersion objective, images were acquired at 512 × 512 pixel size. Experiments were 
performed at least in triplicates, elliptical regions of interest (ROI) were selected and data were analysed using 
Leica Application Suite.
ATP stimulation. HEK293T cells were transfected with GCaMP6f variants using Fugene HD following the 
manufacturer’s recommendations. Imaging was performed 16–24 h post-transfection at 37 °C (OKO lab incu-
bation chamber) in a 35-mm glass bottom dish (MatTek) with a 3i Marianas spinning-disk confocal microscope 
equipped with a Zeiss AxioObserver Z1, a 40 × 1.3 NA oil immersion objective and a 3i Laserstack as excitation 
light source (488 nm). Emitted light was collected through a single bandpass filter (Yokogawa CSU-X filter wheel) 
onto a CMOS camera (Hamamatsu, ORCA Flash 4.0; 1152 × 1656 pixels). Cells were stimulated with 100 μ M 
ATP and images were collected at 1 s intervals for 40 seconds. Elliptical ROI were stacked using ImageJ program. 
Data obtained from 14–24 cells was plotted and analysed on GraphPad Prism 6. Fluorescence decay times were 
determined from single exponential fits to the data.
Two-photon imaging of GCaMP6f, GCaMP6fu and mGCaMP6 RS-1 EF-4 in hippocampal slices. 
Sprague Dawley rats were purchased from Charles River. All experiments were conducted in accordance with 
the Canadian Council on Animal Care standards and guidelines, with approval of the Dalhousie University 
Committee on Laboratory Animals. Transverse organotypic hippocampal slices (350  μ m) were made from brains 
of rat pups aged 6 to 8 postnatal days humanely killed by Schedule 1 procedure (anesthetic (ketamine) overdose 
followed by decapitation) and cultured on Millicell CM membranes for 5 to 6 days35,36. Hippocampal slices were 
transfected using biolistics as described previously37. Slice preparations were transferred to a recording chamber 
and superfused at 28 °C with artificial cerebrospinal fluid (containing 120 mM NaCl, 3 mM KCl, 2 mM MgSO4, 
4 mM CaCl2, 1.2 mM NaH2PO4 and 11 mM glucose) saturated with a gas mixture of 95% O2/5% CO2.
An upright epifluorescence microscope (Olympus BX51WI) with a 60 × 1.0 NA IR water immersion objective 
(Olympus) and an MRC1024MP (Bio-Rad Microscience, Hemel Hampstead, United Kingdom) laser scanner 
with nondescanned photomultiplier tube detectors were used to view slices. Two-photon imaging was carried out 
1–4 days post-transfection using a MaiTai titanium sapphire laser) at 930 nm.
Action potentials were evoked and recorded in expressing CA1 pyramidal neurons using a sharp intracel-
lular electrode (60–80 MΩ) filled with 3 M KCl in 20 mM 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic 
acid. Line scans taken at 2 ms interval across proximal apical dendrites were collected to determine the calcium 
transients measured as Δ F/F0 (defined as Δ F/F0 = 100 (Ftransient-Finitial)/(Finitial-Fbackground) corresponding to 5 AP-s 
evoked by brief depolarizing current injection at frequencies between 10–100 Hz via a Multiclamp 700B amplifier 
(Molecular Devices, California). Ca2+ decay kinetics of GCaMP6 variants were determined by monitoring fluo-
rescence changes evoked by 5 APs at 100 Hz.
Electrophysiological and imaging data were collected and analysed with software from AxoGraph (AxoGraph 
Scientific, Sydney, Australia), LaserSharp (Bio-Rad Microscience) and ImageJ38.
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This Article contains a typographical error. In the Results section,
‘With measured molar extinction coefficients εo(497 nm) of 50294 ± 259 M−1 cm−1 for Ca2+-saturated GCaMP6f 
and 1564 ± 1140 M−1 cm−1 for Ca2+-saturated GCaMP6fu, brightness values of 29673 and 7197 M−1 cm−1 were 
obtained for GCaMP6f and GCaMP6fu, respectively.’
should read:
‘With measured molar extinction coefficients εo(497 nm) of 50294 ± 259 M−1 cm−1 for Ca2+-saturated GCaMP6f 
and 15646 ± 1140 M−1 cm−1 for Ca2+-saturated GCaMP6fu, brightness values of 29673 and 7197 M−1 cm−1 were 
obtained for GCaMP6f and GCaMP6fu, respectively’.
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
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Supplementary Figure S1 
 
 
 
 
Supplementary Figure S1. pH sensitivity and pKa determination of (a) GCaMP6s; (b) 
mGCaMP6s EF-4; (c) mGCaMP6s RS1 EF-3; (d) GCaMP6f; (e) mGCaMP6f EF-4; (f) 
mGCaMP6f RS1 EF-3 (GCaMP6fu); (g) mGCaMP6f RS1 EF-4. Normalised fluorescence in 
presence of 1 mM Ca2+ (■) or 2 mM BAPTA (●); ΔF/F0 (▲). 
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Supplementary Figure S2 
 
 
 
 
Supplementary Figure S2. Comparison of equilibrium Ca2+ binding of EF-hand and peptide 
mutant mGCaMP6s and mGCaMP6f to GCaMP6s and GCaMP6f (20 °C). Equilibrium Ca2+ 
titrations of (a) GCaMP6s (●), mGCaMP6s EF-3 (▲), mGCaMP6s EF-4 (▼) and 
mGCaMP6s EF-3:4 (■); (b) mGCaMP6s RS-1 EF-3 (▲), mGCaMP6s RS-1 EF-4 (▼) and 
mGCaMP6s RS-1 EF-3:4 (■); (c) GCaMP6f (●), mGCaMP6f  EF-3 (▲), mGCaMP6f  EF-4 
(▼) and mGCaMP6f  EF-3:4 (■); (d) mGCaMP6f  RS-1 EF-4 (▼) and mGCaMP6f  RS-1 
EF-3:4 (■). Fluorescence changes are normalised to F0 of 0 and Fmax of 1 and fitted to the Hill 
equation. Fitted curves are represented by solid lines overlaying the data. 
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Supplementary Figure S3 
 
 
 
Supplementary Figure S3. Comparison of equilibrium Ca2+ binding of EF-hand and peptide 
mutant mGCaMP6s and mGCaMP6f to GCaMP6s and GCaMP6f (37 °C). Equilibrium Ca2+ 
titrations for (a) GCaMP6s (●), mGCaMP6s EF-4 (▼) and mGCaMP6s RS-1 EF-3 (▲); (b) 
GCaMP6f (●) and mGCaMP6f EF-4 (▼); (c) mGCaMP6f RS-1 EF-4 (▼). Fluorescence 
changes are normalized to F0 of 0 and Fmax of 1 and fitted to the Hill equation ((a) and (b)) 
and to a two-site binding model (c). Fitted curves are represented by solid lines overlaying 
the data points.   
  
5 
 
Supplementary Figure S4 
 
 
 
 
Supplementary Figure S4. Ca2+ dissociation kinetics of EF-hand and peptide mutant 
mGCaMP6s and mGCaMP6f compared with GCaMP6s and GCaMP6f (20 °C). Ca2+ 
dissociation time courses of (a) GCaMP6s (▬), mGCaMP6s EF-3 (▬), mGCaMP6s EF-4 
(▬) and mGCaMP6s EF-3:4 (▬); (b) mGCaMP6s RS-1 EF-3 (▬), mGCaMP6s RS-1 EF-4 
(▬) and mGCaMP6s RS-1 EF-3:4 (▬); (c) GCaMP6f (▬), mGCaMP6f  EF-3 (▬), 
mGCaMP6f  EF-4 (▬) and mGCaMP6f  EF-3:4 (▬); (d) mGCaMP6f  RS-1 EF-4 (▬) and 
mGCaMP6f  RS-1 EF-3:4 (▬). Fluorescence intensities are relative to Ca2+-bound GCaMP6s 
(panels a and b) and to Ca2+-bound GCaMP6f (panels c and d).  
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Supplementary Figure S5 
 
 
 
 
Supplementary Figure S5. Arrhenius plots of the observed rates for Ca2+ dissociation of EF-
hand and peptide mutant mGCaMP6s and mGCaMP6f compared with GCaMP6s and 
GCaMP6f. (a) GCaMP6s (▬), mGCaMP6s EF-3 (▬), mGCaMP6s EF-4 (▬) and 
mGCaMP6s EF-3:4 (▬); (b) mGCaMP6s RS-1 EF-3 (▬), mGCaMP6s RS-1 EF-4 (▬) and 
mGCaMP6s RS-1 EF-3:4 (▬); (c) GCaMP6f (▬), mGCaMP6f  EF-3 (▬), mGCaMP6f  EF-
4 (▬) and mGCaMP6f  EF-3:4 (▬); (d) mGCaMP6f  RS-1 EF-4 (▬) and mGCaMP6f  RS-1 
EF-3:4 (▬).  For mGCaMP6 with biphasic kinetics, the slower rate is shown in dotted line 
and the faster rate is in solid line.  
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Supplementary Figure S6 
 
 
 
Supplementary Figure S6. Regression statistics for data in Fig. 1f. 
  
GCaMP6f GCaMP6f RS-1 EF-3
Best-fit values
Slope -7322 ± 282.0 -5624 ± 202.9
Y-intercept when X=0.0 25.85 ± 0.9346 23.64 ± 0.6734
X-intercept when Y=0.0 0.003531 0.004204
1/slope -0.0001366 -0.0001778
95% Confidence Intervals
Slope -7910 to -6734 -6045 to -5204
Y-intercept when X=0.0 23.90 to 27.80 22.25 to 25.04
X-intercept when Y=0.0 0.003514 to 0.003550 0.004142 to 0.004276
Goodness of Fit
R square 0.9712 0.9722
Sy.x 0.0867 0.06573
Is slope significantly non-zero?
F 674 768.7
DFn, DFd 1.000, 20.00 1.000, 22.00
P value < 0.0001 < 0.0001
Deviation from zero? Significant Significant
Data
Number of X values 7 7
Maximum number of Y replicates 4 4
Total number of values 22 24
Number of missing values 27 25
Equation Y = -7322*X + 25.85 Y = -5624*X + 23.64
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Supplementary Figure S7 
 
 
 
Supplementary Figure S7. Ca2+ association kinetics of GCaMP6s and its EF-hand and 
peptide mutants at 20 °C (a) GCaMP6s; (b) mGCaMP6s EF-3; (c) mGCaMP6s EF-4; (d) 
mGCaMP6s EF-3:4; (e) mGCaMP6s RS-1 EF-3; (f) mGCaMP6s RS-1 EF-4. In each panel, 
the left hand side plot shows the [Ca2+] dependence of the observed rate(s) (kobs) and on the 
right hand side stopped-flow records obtained at the specified final [Ca2+] values are 
displayed. For mGCaMP6 with biphasic association kinetics (panels a-e), the dominant 
component (larger fluorescence amplitude) is shown in black. The relative amplitudes of the 
fast and slow phases are given in parentheses. Fluorescence changes are normalised to F0 of 0 
and maximum of 1.  
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Supplementary Figure S8 
 
 
 
 
Supplementary Figure S8. Ca2+ association kinetics of the EF-hand and peptide mutants of 
GCaMP6f (20 °C). (a) mGCaMP6f EF-3; (b) mGCaMP6f EF-4; (c) mGCaMP6f EF-3:4; (d) 
mGCaMP6f RS-1 EF-4. In each panel, the left hand side plot shows the [Ca2+] dependence of 
the observed rate(s) (kobs) and on the right hand side stopped-flow records obtained at the 
specified final [Ca2+] values are displayed. For mGCaMP6 with biphasic association kinetics 
(panels a, b and d), the dominant component (larger relative fluorescence amplitude) is 
shown in black. The relative amplitudes of the fast and slow phases are given in parentheses. 
Fluorescence changes are normalised to F0 of 0 and maximum of 1.  
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Supplementary Figure S9 
 
 
 
Supplementary Figure S9. Regression statistics for data in Fig. 2e. 
  
GCaMP6f slow GCaMP6f fast GCaMP6f RS-1 EF-3
Best-fit values
Slope -2971 ± 300.0 -1602 ± 602.0 -7735 ± 1006
Y-intercept when X=0.0 13.72 ± 1.003 11.29 ± 2.046 31.33 ± 3.376
X-intercept when Y=0.0 0.004619 0.007049 0.00405
1/slope -0.0003366 -0.0006243 -0.0001293
95% Confidence Intervals
Slope -3589 to -2353 -2914 to -290.2 -9879 to -5592
Y-intercept when X=0.0 11.66 to 15.79 6.833 to 15.75 24.14 to 38.52
X-intercept when Y=0.0 0.004399 to 0.004955 0.005405 to 0.02354 0.003899 to 0.004317
Goodness of Fit
R square 0.7969 0.3711 0.7977
Sy.x 0.1221 0.1277 0.1737
Is slope significantly non-zero?
F 98.09 7.082 59.14
DFn, DFd 1.000, 25.00 1.000, 12.00 1.000, 15.00
P value < 0.0001 0.0207 < 0.0001
Deviation from zero? Significant Significant Significant
Data
Number of X values 8 5 5
Maximum number of Y replicates 5 4 4
Total number of values 27 14 17
Number of missing values 29 42 39
Equation Y = -2971*X + 13.72 Y = -1602*X + 11.29 Y = -7735*X + 31.33
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Supplementary Figure S10 
 
 
 
Supplementary Figure S10. Ca2+ dependence of association kinetics of selected probes at 37 
°C. [Ca2+] dependence of the observed rate(s) (kobs) of (a) GCaMP6s; (b) mGCaMP6s EF-4; 
(c) mGCaMP6s RS-1 EF-3 and (d) mGCaMP6f EF-4. For mGCaMP6s RS-1 EF-3 biphasic 
association kinetics, the dominant component (larger relative fluorescence amplitude) is 
shown in black. The relative amplitudes of the fast and slow phases are given in parentheses.   
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Supplementary Figure S11 
 
 
 
Supplementary Figure S11. Arrhenius plots of the observed rates for Ca2+ association of 
EF-hand and peptide mutant mGCaMP6s and mGCaMP6f compared with GCaMP6s and 
GCaMP6f. (a) GCaMP6s (▬), mGCaMP6s EF-3 (▬), mGCaMP6s EF-4 (▬) and 
mGCaMP6s EF-3:4 (▬); (b) mGCaMP6s RS-1 EF-3 (▬) and mGCaMP6s RS-1 EF-4 (▬); 
(c) GCaMP6f (▬), mGCaMP6f  EF-3 (▬), mGCaMP6f  EF-4 (▬) and mGCaMP6f  EF-3:4 
(▬); (d) mGCaMP6f  RS-1 EF-4 (▬).  For mGCaMP6 with biphasic kinetics, the slower rate 
is shown in dotted line and the faster rate is in solid line.  
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Supplementary Figure S12 
 
 
 
 
 
 
Supplementary Figure S12. Imaging of GCaMP6-derived probes in HEK293T cells. 
Fluorescence dynamic ranges of selected probes obtained following ionomycin stimulation. 
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Supplementary Figure S13 
 
 
Supplementary Figure S13. Ca2+ response of mGCaMP6f RS-1 EF-4 in stimulated 
HEK293T cells and post-synaptic CA1 neurons. (a) Ca2+ transients were triggered by 
exposure of HEK293T cells to 100 M ATP. Time course of response of mGCaMP6f RS-1 
EF-4 was recorded with 1 s intervals. t1/2 for mGCaMP6f RS-1 EF-4 of 2.2 ± 0.04 s was 
significantly different from that for GCaMP6f (9.4 ± 0.2 s).  (b) Ca2+ response of mGCaMP6f 
RS-1 EF-4 in stimulated post-synaptic CA1 neurons is imaged by two-photon microscopy. 
GCaMP6f RS-1 EF-4 stimulated (3 cells, n number of recordings in brackets) by 5 AP-s at 10 
Hz (n = 20), 20 Hz (n = 27), 40 Hz (n = 30), 50 Hz (n = 30), 75 Hz (n = 30) and 100 Hz (n = 
30). Grey shaded areas indicate the duration of stimulation. The achieved maximum ΔF/F0 
values are plotted against time. Inset image: representative image baseline expression of 
mGCaMP6f RS-1 EF-4 in CA1 pyramidal neurons with white line in the position of the line 
scan.  
 
15 
 
Supplementary Table S1. Summary of the biophysical characteristics of single EF-hand mutated 
mGCaMP6s and mGCaMP6f probes. 
 
aBiphasic association kinetic records were fitted with two exponentials. The rate of each phase is given with the relative amplitudes in 
parentheses. bMeasurements were made at 20, 25 and 30°C. The rate was too fast to measure at 37°C, thus value was extrapolated 
from the Arrhenius plot assuming the gradient remaining unchanged (Fig. 1f). cValues in parentheses represent relative fluorescence 
amplitudes of two binding sites. n.d. denotes not determined. 
 
Fr(-Ca
2+) Fr(+Ca
2+
) 
Fr(+Ca
2+
) /       
Fr(-Ca
2+
) 
Kd                                   
(M) 
n 
kon(lim)
a 
t1/2(on) 
koff
a 
t1/2(off) 
(s-1) 
(ms) 
(s-1) 
(ms) 
  
 
 
GCaMP6s  20 °C 1.0 ± 0.1 27.3 ± 0.5 27.3 ± 0.9 0.11 ± 0.01 3.4 ± 0.1 306 ± 12 (0.4) 2 0.9 769 
  
     
31 ± 1 (0.6) 22 
  
GCaMP6s  37 °C 1.0 ± 0.01 23.3 ± 0.1 23.3 ± 0.3 0.054 ± 0.005 3.0 ± 0.1 324 ± 23 (0.1) 2 2.0 ± 0.1 346 
      59 ± 3 (0.9) 12   
mGCaMP6s EF-3 20 °C 1.1 ± 0.2 19.4 ± 0.2 18.1 ± 2.2 0.21 ± 0.01 3.2 ± 0.1 180 ± 5 (0.2) 4 0.9 769 
      
46 ± 2 (0.8) 15 
  
mGCaMP6s EF-3 37 °C n.d. n.d. n.d. n.d. n.d. 187 ± 6 (0.5) 4 2.6 ± 0.1 266 
      61 ± 3 (0.5) 11   
mGCaMP6s EF-4 20 °C 0.7 ± 0.1 20.0 ± 0.3 28.6 ± 1.1 0.61 ± 0.01 2.5 ± 0.1 120 ± 4 (0.4) 6 0.9 769 
  
     
27 ± 2 (0.6) 26 
  
mGCaMP6s EF-4 37 °C 0.9 ± 0.04 21.2 ± 1.0 23.9 ± 0.3 0.170 ± 0.005 3.7 ± 0.4 162 ± 22 (0.2) 4 4.2 ± 0.2 165 
      49 ± 4 (0.8) 14   
mGCaMP6s RS-1 EF-3 20 °C 1.2 ± 0.1 21.1 ± 0.1 18.1 ± 0.7 0.62 ± 0.01 4.2 ± 0.1 45 ± 2 (0.6) 15 3.2 ± 0.1 216 
      
17 ± 1 (0.4) 41 
  
mGCaMP6s RS-1 EF-3 37 °C 1.0 ± 0.01 14.1 ± 0.1 14.1 ± 0.2 0.36 ± 0.01 2.7 ± 0.2 110 ± 1 (0.9) 6 13 ± 1 53 
      
11 ± 1 (0.1) 63 
  
mGCaMP6s RS-1 EF-4 20 °C 0.7 ± 0.1 21.8 ± 0.7 30.7 ± 1.1 1.4 ± 0.1 3.1 ± 0.1 13 ± 1 53 1.7 407 
mGCaMP6s RS-1 EF-4 37 °C n.d. n.d. n.d. n.d. n.d. 39 ± 3 18 39 ± 3 18 
GCaMP6f  20 °C 0.9 ± 0.1 14.4 ± 3.4 14.6 ± 2.4 0.22 ± 0.01 2.8 ± 0.1 315 ± 9 (0.3) 2 2.4 ± 0.1 288 
       38 ± 1 (0.7) 18   
GCaMP6f  37 °C 1.0 ± 0.1 13.8 ± 0.04 13.2 ± 0.1 0.088 ± 0.009 3.4 ± 0.1 66 ± 1 10 11 ± 1 63 
          
mGCaMP6f EF-3 20 °C 1.3 ± 0.1 15.6 ± 0.3 12.4 ± 0.8 0.30 ± 0.03 3.4 ± 0.1 197 ± 6 (0.6) 4 4.5 154 
      60 ± 2 (0.4) 12   
mGCaMP6f EF-3 37 °C n.d. n.d. n.d. n.d. n.d. 255 ± 20 (0.6) 3 21 ± 1 33 
      
76 ± 3 (0.4) 9 
  
mGCaMP6f EF-4 20 °C 1.1 ± 0.1 21.2 ± 0.8 20.3 ± 2.0 1.6 ± 0.1 2.4 ± 0.1 155 ± 10 (0.4) 4 4.7 147 
       31 ± 2 (0.6) 22   
mGCaMP6f EF-4 37 °C 
 
1.0 ± 0.09 
 
16.1 ± 0.3 
 
15.8 ± 1 
 
0.84 ± 0.03 
 
1.8 ± 0.1 
 
64 ± 1 
 
11 
 
20 ± 1 
 
35 
 
mGCaMP6f RS-1 EF-3 20 °C 
(GCaMP6fu) 1.0 ± 0.1 5.1 ± 0.4 5.1 ± 0.1 0.89 ± 0.01 3.0 ± 0.1 142 ± 4 4.9 89 ± 1 7.8 
mGCaMP6f RS-1 EF-3 37 °C 
(GCaMP6fu) 0.9 ± 0.1 3.8 ± 0.2 4.1 ± 0.2 0.34 ±0.01 3.0 ± 0.3 546
b 1.3 245 ± 10 2.8 
mGCaMP6f RS-1 EF-4 20 °C 0.9 ± 0.1 16.9 ± 0.4 19.5 ± 0.4 3.0 ± 0.2 (0.8)c 2.1 ± 0.2 124 ± 9 (0.3) 5.6 44 ± 1 16 
    229 ± 24 (0.2)c 1.2 ± 0.1 22 ± 1 (0.7)  31   
mGCaMP6f RS-1 EF-4 37 °C 0.9 ± 0.1 12.9 ± 0.1 14.6 ± 1.2 0.87 ± 0.14 (0.3)c 1.8 ± 0.4 210 ± 10 (0.7) 3.3 199 ± 3 3.5 
    961 ± 212 (0.7)c 1 9 ± 1 (0.3) 77   
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Supplementary Table S2. Summary of the biophysical characteristics of double EF-hand 
mutated mGCaMP6s and mGCaMP6f probes. 
  
 
 
aBiphasic kinetic records were fitted with two exponentials. The rate of each phase is given with the relative amplitudes in 
parentheses. bMeasurements were made at 20, 25 and 30°C. The rates was too fast to measure at 37°C, thus the value was 
extrapolated from the Arrhenius plot assuming the gradient remaining unchanged (Supplementary Fig. S4b,S9c). cValues in 
parentheses represent relative fluorescence amplitudes of two binding sites. Error represents the standard error of the estimate for the 
average of three records. n.d. denotes not determined. 
  
 
Fr(-Ca
2+) Fr(+Ca
2+
) 
Fr(+Ca
2+
) /       
Fr(-Ca
2+
) 
Kd                                   
(M) 
n 
kon(lim)  t1/2(on) koff t1/2(off) 
(s-1) (ms) (s-1) (ms) 
mGCaMP6s EF-3:4 20 °C 1.0 ± 0.1 5.8 ± 2.3 5.8 ± 1.2 2.7 ± 0.1 (0.2) 1.8 ± 0.1 141 ± 8 (0.2)a 5 13.4 ± 0.1 52 
  
19.0 ± 0.2 19.1 ± 0.3 466 ± 35 (0.8) 1 16 ± 1 (0.8)a 43 
  
mGCaMP6s EF-3:4 37 °C n.d. n.d. n.d. n.d. n.d. 74 ± 2 9 93 ± 9 7 
mGCaMP6s RS-1 EF-3:4 20 °C 1.1 ± 0.1 1.3 ± 0.4 1.3 ± 0.3 3.3 ± 0.2 (0.2)c 1.8 ± 0.1 n.d. n.d. 135 ± 3 (0.6)a 5 
  5.8 ± 0.3 5.4 ± 0.4 6335 ± 874 (0.8)c 1   12 ± 1 (0.4)a 58 
mGCaMP6s RS-1 EF-3:4 37 °C n.d. n.d. n.d. n.d. n.d. n.d. n.d. 420b 2 
        4.2* 165 
mGCaMP6f EF-3:4 20 °C 0.9 ± 0.1 2.0 ± 0.1 2.2 ± 0.2 2.2 ± 0.1 (0.3)c 1.7 ± 0.1 48 ± 1 14 67 ± 5 (0.4)a 10 
  5.7 ± 0.3 6.2 ± 0.4 3606 ± 261 (0.7)c 1   3.0 ± 0.1 (0.6)a 231 
mGCaMP6f EF-3:4 37 °C n.d. n.d. n.d. n.d. n.d. 276.0b 3 174 ± 5 (0.8)a 4 
        13 ± 1 (0.2)a 53 
mGCaMP6f RS-1 EF-3:4 20 °C 1.0 ± 0.1 1.4 ± 0.1 1.4 ± 0.1 1.2 ± 0.1 2.5 ± 0.2 n.d. n.d 65 ± 3 11 
mGCaMP6f RS-1 EF-3:4 37 °C n.d. n.d. n.d. n.d. n.d. n.d. n.d. 233 ± 18 3 
17 
 
 
 
Supplementary Table S3 
 
 
 
 
k+1 k -1 k+2 k -2 k+3 k -3 k+4 k -4 k+5 k -5 k+6 k -6 k+7 k -7 k+8 k -8 K d
(M-1 s-1) (s-1) (M-1 s-1) (s-1) (M-1 s-1) (s-1) (s-1) (s-1) (M-1 s-1) (s-1) (M-1 s-1) (s-1) (M-1 s-1) (s-1) (s-1) (s-1) (M)
GCaMP6f 20 °C 770 1100 15038 935 786 1.0E-02 395 1210 84 252 3464 980 2185 19 548 5.0E-03 54 14 0.22
GCaMP6f 37 °C 770 1100 15038 935 786 2.1E-05 408 1242 84 252 3464 264 2185 19 548 3.8E-05 59 14 0.088
mGCaMP6f RS-1 EF-3 (GCaMP6fu ) 20 °C 770 1100 15038 935 337867 2.9E-03 138 37  -  - 84 23651 963 1793 1232 8.0E-04 20 15 0.89
mGCaMP6f RS-1 EF-3 (GCaMP6fu ) 30 °C 770 1100 15038 935 337867 2.9E-03 223 71  -  - 84 23651 963 1793 1232 1.8E-03 16 15 0.57
F 1 F 2
